Payment overview · 2025
General Payments
$1,444.41
71 reported records · 22 companies
Healthcare provider profile · identity verified
Kyi Win Yu, MD
Allopathic & Osteopathic Physicians|Family Medicine · ROCKAWAY BEACH, NY · NPI 1427095686
Verified facts
What the public records show
CMS Open Payments records show Kyi Win Yu, MD received $1,444.41 in general payments during 2025 across 71 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 16.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 28 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga, Jardiance, Mounjaro.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 216 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Lumigan by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 241 claims for Synthroid by this doctor in 2024.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Prolia by this doctor in 2024.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 41 claims for Myrbetriq by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 191 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NEXIUM as an associated drug or biological on 464 records involving 299 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Nexium by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 497 claims for Jardiance by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNJARDY as an associated drug or biological on 33 records involving 33 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Synjardy by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 497 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 224 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 206 claims for Trulicity by this doctor in 2024.
Takeda Pharmaceuticals U.S.A., Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRINTELLIX as an associated drug or biological on 37075 records involving 14402 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Trintellix by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $243.78 | 16.9% | 17 | 2025 |
| Kowa Pharmaceuticals America, Inc. | Unresolved — no canonical attribution shown | $139.61 | 9.7% | 11 | 2025 |
| Regeneron Healthcare Solutions, Inc. | Unresolved — no canonical attribution shown | $125.00 | 8.7% | 1 | 2025 |
| Xeris Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $116.60 | 8.1% | 6 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $109.75 | 7.6% | 5 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $104.11 | 7.2% | 4 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $101.54 | 7.0% | 5 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $64.10 | 4.4% | 2 | 2025 |
| Ardelyx, Inc. | Unresolved — no canonical attribution shown | $60.70 | 4.2% | 2 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $57.23 | 4.0% | 3 | 2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $45.85 | 3.2% | 2 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $45.02 | 3.1% | 2 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $43.34 | 3.0% | 2 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $25.86 | 1.8% | 1 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $25.28 | 1.8% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $25.01 | 1.7% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $22.04 | 1.5% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $21.30 | 1.5% | 1 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $17.50 | 1.2% | 1 | 2025 |
| Almatica Pharma LLC | Unresolved — no canonical attribution shown | $16.99 | 1.2% | 1 | 2025 |
| Eisai Inc. | Unresolved — no canonical attribution shown | $16.98 | 1.2% | 1 | 2025 |
| Renalytix AI, Inc. | Unresolved — no canonical attribution shown | $16.82 | 1.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $1,444.41 | 71 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ABILIFY ASIMTUFII Normalized: abilify asimtufii |
Drug | Otsuka America Pharmaceutical, Inc. | $193.95 | 14 | 2025 |
Source payment records
|
|||||
| ZORYVE Normalized: zoryve |
Drug | Kowa Pharmaceuticals America, Inc. | $139.61 | 11 | 2025 |
Source payment records
|
|||||
| DUPIXENT Normalized: dupixent |
Biological | Regeneron Healthcare Solutions, Inc. | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $104.11 | 4 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $104.11 | 4 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $101.54 | 5 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $87.25 | 4 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $71.87 | 4 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $64.10 | 2 | 2025 |
Source payment records
|
|||||
| RECORLEV Normalized: recorlev |
Drug | Xeris Pharmaceuticals, Inc. | $61.31 | 3 | 2025 |
Source payment records
|
|||||
| IBSRELA Normalized: ibsrela |
Drug | Ardelyx, Inc. | $60.70 | 2 | 2025 |
Source payment records
|
|||||
| GVOKE HYPOPEN Normalized: gvoke hypopen |
Drug | Xeris Pharmaceuticals, Inc. | $55.29 | 3 | 2025 |
Source payment records
|
|||||
| VPRIV Normalized: vpriv |
Biological | Takeda Pharmaceuticals U.S.A., Inc. | $45.85 | 2 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $45.02 | 2 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $43.34 | 2 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $39.54 | 2 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $25.86 | 1 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $25.28 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $25.01 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $25.01 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $22.50 | 1 | 2025 |
Source payment records
|
|||||
| ABILIFY MAINTENA Normalized: abilify maintena |
Drug | Otsuka America Pharmaceutical, Inc. | $21.88 | 2 | 2025 |
Source payment records
|
|||||
| WATCHMAN FLX Normalized: watchman flx |
Device | Boston Scientific Corporation | $21.30 | 1 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $17.50 | 1 | 2025 |
Source payment records
|
|||||
| LOREEV XR Normalized: loreev xr |
Drug | Almatica Pharma LLC | $16.99 | 1 | 2025 |
Source payment records
|
|||||
| TERIPARATIDE Normalized: teriparatide |
Drug | Almatica Pharma LLC | $16.99 | 1 | 2025 |
Source payment records
|
|||||
| Leqembi Normalized: leqembi |
Drug | Eisai Inc. | $16.98 | 1 | 2025 |
Source payment records
|
|||||
| KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT Normalized: kidneyintelx blood collection convenience kit |
Device | Renalytix AI, Inc. | $16.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 191 | exact normalized | Medicare Part D |
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 497 | exact normalized | Medicare Part D |
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 224 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
216 | 51 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
241 | 45 |
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
46 | 30 |
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
41 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
191 | 29 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | NEXIUM open payments reported associated product |
CMS Open Payments — General Payments 464 supporting records · 299 recipient NPIs · example record 1206134180 |
Nexium · 2024 Exact normalized brand match · 1 Part D row |
40 | suppressed by CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
497 | 73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | SYNJARDY open payments reported associated product |
CMS Open Payments — General Payments 33 supporting records · 33 recipient NPIs · example record 1222725005 |
Synjardy · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
497 | 73 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
224 | 36 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
206 | 38 |
| Takeda Pharmaceuticals U.S.A., Inc. Exact reporting entity; no affiliate inference |
2025 | TRINTELLIX open payments reported associated product |
CMS Open Payments — General Payments 37075 supporting records · 14402 recipient NPIs · example record 1223616266 |
Trintellix · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1510 | 305 |
| Amlodipine Besylate | Amlodipine Besylate | 1027 | 203 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 833 | 190 |
| Omeprazole | Omeprazole | 830 | 195 |
| Zolpidem Tartrate | Zolpidem Tartrate | 787 | 136 |
| Losartan Potassium | Losartan Potassium | 720 | 152 |
| Metformin Hcl | Metformin Hcl | 685 | 147 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 668 | 130 |
| Metoprolol Succinate | Metoprolol Succinate | 663 | 139 |
| Tamsulosin Hcl | Tamsulosin Hcl | 601 | 134 |
| Ozempic | Semaglutide | 509 | 90 |
| Ketoconazole | Ketoconazole | 506 | 166 |
| Jardiance | Empagliflozin | 497 | 73 |
| Gabapentin | Gabapentin | 494 | 105 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 494 | 60 |
| Levothyroxine Sodium | Levothyroxine Sodium | 474 | 111 |
| Furosemide | Furosemide | 465 | 106 |
| Clonazepam | Clonazepam | 456 | 110 |
| Hydrochlorothiazide | Hydrochlorothiazide | 436 | 107 |
| Azelastine Hcl | Azelastine Hcl | 422 | 171 |
| Diclofenac Sodium | Diclofenac Sodium | 408 | 102 |
| Fluticasone Propionate | Fluticasone Propionate | 402 | 182 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 402 | 101 |
| Simvastatin | Simvastatin | 381 | 79 |
| Sertraline Hcl | Sertraline Hcl | 375 | 67 |
| Doxycycline Hyclate | Doxycycline Hyclate | 370 | 262 |
| Pantoprazole Sodium | Pantoprazole Sodium | 363 | 88 |
| Alprazolam | Alprazolam | 361 | 70 |
| Lisinopril | Lisinopril | 349 | 75 |
| Clopidogrel | Clopidogrel Bisulfate | 348 | 74 |
| Mometasone Furoate | Mometasone Furoate | 308 | 92 |
| Januvia | Sitagliptin Phosphate | 307 | 50 |
| Eliquis | Apixaban | 298 | 53 |
| Famotidine | Famotidine | 297 | 72 |
| Quetiapine Fumarate | Quetiapine Fumarate | 289 | 45 |
| Mupirocin | Mupirocin | 280 | 83 |
| Metoprolol Tartrate | Metoprolol Tartrate | 278 | 59 |
| Meloxicam | Meloxicam | 277 | 130 |
| Azithromycin | Azithromycin | 263 | 200 |
| Prednisone | Prednisone | 257 | 132 |
| Montelukast Sodium | Montelukast Sodium | 252 | 52 |
| Synthroid | Levothyroxine Sodium | 241 | 45 |
| Glimepiride | Glimepiride | 236 | 45 |
| Mounjaro | Tirzepatide | 224 | 36 |
| Linzess | Linaclotide | 216 | 51 |
| Escitalopram Oxalate | Escitalopram Oxalate | 210 | 47 |
| Trulicity | Dulaglutide | 206 | 38 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 201 | 51 |
| Enalapril Maleate | Enalapril Maleate | 198 | 36 |
| Farxiga | Dapagliflozin Propanediol | 191 | 29 |
| Carvedilol | Carvedilol | 187 | 43 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 184 | 39 |
| Finasteride | Finasteride | 180 | 49 |
| Ezetimibe | Ezetimibe | 177 | 35 |
| Trazodone Hcl | Trazodone Hcl | 163 | 40 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 159 | 37 |
| Lidocaine | Lidocaine | 158 | 35 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 146 | 26 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 141 | 56 |
| Potassium Chloride | Potassium Chloride | 140 | 34 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 138 | 113 |
| Mirtazapine | Mirtazapine | 136 | 49 |
| Vascepa | Icosapent Ethyl | 134 | 28 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 131 | 25 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 129 | 29 |
| Lorazepam | Lorazepam | 128 | 40 |
| Ammonium Lactate | Ammonium Lactate | 126 | 43 |
| Ibuprofen | Ibuprofen | 125 | 51 |
| Atenolol | Atenolol | 122 | 30 |
| Dexlansoprazole Dr | Dexlansoprazole | 122 | 17 |
| Metformin Hcl Er | Metformin Hcl | 120 | 23 |
| Nystatin | Nystatin | 116 | 20 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 115 | 77 |
| Levofloxacin | Levofloxacin | 114 | 83 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 111 | 57 |
| Fluconazole | Fluconazole | 108 | 60 |
| Meclizine Hcl | Meclizine Hcl | 108 | 44 |
| Ventolin Hfa | Albuterol Sulfate | 108 | 23 |
| Pioglitazone Hcl | Pioglitazone Hcl | 105 | 23 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 104 | 23 |
| Xarelto | Rivaroxaban | 103 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 102 | 30 |
| Chlorthalidone | Chlorthalidone | 100 | 22 |
| Entresto | Sacubitril/Valsartan | 100 | 20 |
| Allopurinol | Allopurinol | 97 | 21 |
| Rybelsus | Semaglutide | 95 | 20 |
| Spironolactone | Spironolactone | 93 | 24 |
| Colchicine | Colchicine | 91 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 89 | 29 |
| Nifedipine Er | Nifedipine | 89 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 86 | 17 |
| Metformin Er Gastric | Metformin Hcl | 86 | 19 |
| Mupirocin | Mupirocin Calcium | 86 | 21 |
| Clobetasol Propionate | Clobetasol Propionate | 85 | 21 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 84 | 25 |
| Valsartan | Valsartan | 84 | 22 |
| Topiramate | Topiramate | 82 | 13 |
| Metronidazole | Metronidazole | 81 | 56 |
| Hydrocortisone | Hydrocortisone | 79 | 34 |
| Amoxicillin | Amoxicillin | 78 | 60 |
| Gentamicin Sulfate | Gentamicin Sulfate | 78 | 30 |
| Memantine Hcl | Memantine Hcl | 77 | 15 |
| Tradjenta | Linagliptin | 77 | 14 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 75 | 13 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 74 | 32 |
| Cephalexin | Cephalexin | 74 | 52 |
| Ibandronate Sodium | Ibandronate Sodium | 74 | 16 |
| Tramadol Hcl | Tramadol Hcl | 73 | 21 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 72 | 56 |
| Lansoprazole | Lansoprazole | 71 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 70 | 14 |
| Sucralfate | Sucralfate | 70 | 25 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 68 | 18 |
| Cilostazol | Cilostazol | 67 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 65 | 13 |
| Terconazole | Terconazole | 65 | 19 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 64 | 15 |
| Acetic Acid | Acetic Acid | 63 | 32 |
| Estradiol | Estradiol | 63 | 18 |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 62 | 47 |
| Procto-Med Hc | Hydrocortisone | 62 | 15 |
| Ramipril | Ramipril | 62 | 14 |
| Valacyclovir | Valacyclovir Hcl | 62 | 27 |
| Celecoxib | Celecoxib | 61 | 11 |
| Baclofen | Baclofen | 60 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 60 | 11 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 59 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 58 | 14 |
| Promethazine Hcl | Promethazine Hcl | 58 | 30 |
| Halobetasol Propionate | Halobetasol Propionate | 57 | 22 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 56 | 18 |
| Diclofenac Sodium Er | Diclofenac Sodium | 56 | 14 |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 56 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 56 | 15 |
| Silver Sulfadiazine | Silver Sulfadiazine | 56 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 56 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 55 | 11 |
| Donepezil Hcl | Donepezil Hcl | 55 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 55 | 16 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 55 | 19 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 54 | 19 |
| Buspirone Hcl | Buspirone Hcl | 54 | 15 |
| Doxepin Hcl | Doxepin Hcl | 53 | 12 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 53 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 53 | 28 |
| Clarithromycin | Clarithromycin | 52 | 45 |
| Dutasteride | Dutasteride | 52 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 52 | suppressed |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 52 | 11 |
| Novolog Flexpen | Insulin Aspart | 51 | 16 |
| Glipizide Er | Glipizide | 50 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 50 | 19 |
| Cefdinir | Cefdinir | 49 | 36 |
| Clonidine Hcl | Clonidine Hcl | 49 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 49 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 48 | 11 |
| Ranolazine Er | Ranolazine | 48 | suppressed |
| Levetiracetam | Levetiracetam | 47 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 46 | 33 |
| Glipizide | Glipizide | 46 | 12 |
| Prolia | Denosumab | 46 | 30 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 45 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 45 | 44 |
| Folic Acid | Folic Acid | 44 | suppressed |
| Lactulose | Lactulose | 44 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 43 | suppressed |
| Linezolid | Linezolid | 43 | 33 |
| Naproxen-Esomeprazole Mag | Naproxen/Esomeprazole Mag | 43 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 43 | suppressed |
| Lamotrigine | Lamotrigine | 42 | suppressed |
| Ssd | Silver Sulfadiazine | 42 | 20 |
| Ciclopirox | Ciclopirox Olamine | 41 | 15 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 41 | 13 |
| Diazepam | Diazepam | 41 | 16 |
| Myrbetriq | Mirabegron | 41 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 40 | 11 |
| Nexium | Esomeprazole Magnesium | 40 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 39 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 39 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 38 | suppressed |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 38 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 38 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 38 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 37 | suppressed |
| Bupropion Xl | Bupropion Hcl | 37 | suppressed |
| Loperamide | Loperamide Hcl | 37 | suppressed |
| Methotrexate | Methotrexate Sodium | 37 | suppressed |
| Haloperidol | Haloperidol | 36 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 36 | 14 |
| Permethrin | Permethrin | 36 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 36 | 16 |
| Ibu | Ibuprofen | 35 | 23 |
| Prevacid | Lansoprazole | 35 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 34 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 34 | suppressed |
| Gemtesa | Vibegron | 33 | suppressed |
| Nitroglycerin | Nitroglycerin | 33 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 32 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 31 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 30 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 30 | suppressed |
| Yuvafem | Estradiol | 30 | suppressed |
| Latanoprost | Latanoprost | 29 | suppressed |
| Olanzapine | Olanzapine | 29 | suppressed |
| Pioglitazone-Glimepiride | Pioglitazone Hcl/Glimepiride | 29 | suppressed |
| Roflumilast | Roflumilast | 28 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 27 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 27 | suppressed |
| Movantik | Naloxegol Oxalate | 27 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 27 | suppressed |
| Tadalafil | Tadalafil | 27 | suppressed |
| True Comfort Pro Alcohol Pads | Alcohol Antiseptic Pads | 27 | suppressed |
| Azelastine-Fluticasone | Azelastine/Fluticasone | 26 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 26 | suppressed |
| Fluocinolone Acetonide | Fluocinolone Acetonide | 26 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | suppressed |
| Paroxetine Er | Paroxetine Hcl | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Prozac | Fluoxetine Hcl | 26 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 25 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Crestor | Rosuvastatin Calcium | 25 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 25 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 24 | suppressed |
| Irbesartan | Irbesartan | 24 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 24 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 24 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | 15 |
| Icosapent Ethyl | Icosapent Ethyl | 23 | suppressed |
| Proctozone-Hc | Hydrocortisone | 23 | suppressed |
| Tacrolimus | Tacrolimus | 23 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 22 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 22 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 22 | suppressed |
| Mestinon | Pyridostigmine Bromide | 22 | suppressed |
| Naproxen | Naproxen | 22 | 14 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 22 | 22 |
| Pregabalin | Pregabalin | 22 | suppressed |
| Anastrozole | Anastrozole | 21 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 21 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 21 | 18 |
| Dupixent Pen | Dupilumab | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Temazepam | Temazepam | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 20 | suppressed |
| Digoxin | Digoxin | 20 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 19 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 19 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 19 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 19 | suppressed |
| Invokana | Canagliflozin | 19 | suppressed |
| Pimecrolimus | Pimecrolimus | 19 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 19 | 15 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 18 | suppressed |
| Flunisolide | Flunisolide | 18 | suppressed |
| Ivermectin | Ivermectin | 18 | suppressed |
| Levemir Flexpen | Insulin Detemir | 18 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 18 | suppressed |
| Ursodiol | Ursodiol | 18 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Epinephrine | Epinephrine | 17 | suppressed |
| Methylprednisolone | Methylprednisolone | 17 | 14 |
| Nyamyc | Nystatin | 17 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 17 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 17 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 17 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 16 | suppressed |
| Fluocinolone Acetonide Oil | Fluocinolone Acetonide Oil | 16 | suppressed |
| Butorphanol Tartrate | Butorphanol Tartrate | 15 | suppressed |
| Febuxostat | Febuxostat | 15 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Lumigan | Bimatoprost | 15 | suppressed |
| Premarin | Estrogens, Conjugated | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 15 | suppressed |
| Tobramycin | Tobramycin | 15 | 15 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Albendazole | Albendazole | 14 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 14 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 14 | 14 |
| Praluent Pen | Alirocumab | 14 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 14 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 14 | suppressed |
| Telmisartan | Telmisartan | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Xiidra | Lifitegrast | 14 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 13 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Repatha Sureclick | Evolocumab | 13 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Alogliptin-Pioglitazone | Alogliptin Benz/Pioglitazone | 12 | suppressed |
| Ambien Cr | Zolpidem Tartrate | 12 | suppressed |
| Amcinonide | Amcinonide | 12 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 12 | suppressed |
| Calcipotriene | Calcipotriene | 12 | suppressed |
| Ciclopirox | Ciclopirox | 12 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 12 | suppressed |
| Diflorasone Diacetate | Diflorasone Diacetate | 12 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 12 | suppressed |
| Lamivudine-Zidovudine | Lamivudine/Zidovudine | 12 | suppressed |
| Lopinavir-Ritonavir | Lopinavir/Ritonavir | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 12 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 12 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 12 | suppressed |
| Alogliptin-Metformin | Alogliptin Benz/Metformin Hcl | 11 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Ciprofloxacin-Dexamethasone | Ciprofloxacin Hcl/Dexameth | 11 | suppressed |
| Dexilant | Dexlansoprazole | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Humira(Cf) Pen | Adalimumab | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Istalol | Timolol Maleate | 11 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 11 | suppressed |
| Nateglinide | Nateglinide | 11 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 11 | suppressed |
| Oxiconazole Nitrate | Oxiconazole Nitrate | 11 | suppressed |
| Plavix | Clopidogrel Bisulfate | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
| Tretinoin | Tretinoin | 11 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 11 | suppressed |
| Zoloft | Sertraline Hcl | 11 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,444.41 · 71 records | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII, ABILIFY MAINTENA, Auvelity, BREZTRI, COLLAGENASE SANTYL, Cologuard Collection Kit, DUPIXENT, FARXIGA, GVOKE HYPOPEN, IBSRELA, JARDIANCE, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, LOREEV XR, Leqembi, MOUNJARO, OTEZLA, QULIPTA, RECORLEV, REPATHA, REXULTI, TERIPARATIDE, VOQUEZNA, VPRIV, Veozah, WATCHMAN FLX, ZENPEP, ZEPBOUND, ZORYVE | 14 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error